151 related articles for article (PubMed ID: 14630275)
1. Uterine sarcoma: twenty-seven years of experience.
Livi L; Paiar F; Shah N; Blake P; Villanucci A; Amunni G; Barca R; Judson I; Lodge N; Meldolesi E; Simontacchi G; Piperno G; Galardi A; Scoccianti S; Biti GP; Harmer C
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1366-73. PubMed ID: 14630275
[TBL] [Abstract][Full Text] [Related]
2. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
3. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of 105 cases with uterine sarcoma.
Yoney A; Eren B; Eskici S; Salman A; Unsal M
Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
[TBL] [Abstract][Full Text] [Related]
5. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità.
Ferrer F; Sabater S; Farrús B; Guedea F; Rovirosa A; Anglada L; Delannes M; Marín S; DuBois JB; Daly-Schveitzer N
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):47-52. PubMed ID: 10219793
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma.
Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):191-7. PubMed ID: 21985942
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
9. Treatment of uterine sarcoma at the University of Florence from 1980-2001.
Livi L; Paiar F; Meldolesi E; Simontacchi G; Amunni G; Barca R; Villanucci A; Scoccianti S; Piperno G; Biti G
Tumori; 2005; 91(2):139-43. PubMed ID: 15948541
[TBL] [Abstract][Full Text] [Related]
10. [Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].
Coquard R; Romestaing P; Ardiet JM; Mornex F; Sentenac I; Gérard JP
Bull Cancer; 1997 Jun; 84(6):625-9. PubMed ID: 9295866
[TBL] [Abstract][Full Text] [Related]
11. Treatment of uterine sarcoma. A survey of 49 patients.
Soumarová R; Horová H; Seneklová Z; Ruzicková J; Horová I; Budíková M; Slampa P; Kalábová R
Arch Gynecol Obstet; 2002 Apr; 266(2):92-5. PubMed ID: 12049303
[TBL] [Abstract][Full Text] [Related]
12. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998.
Livi L; Andreopoulou E; Shah N; Paiar F; Blake P; Judson I; Harmer C
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):261-8. PubMed ID: 15214650
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
[TBL] [Abstract][Full Text] [Related]
14. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
[TBL] [Abstract][Full Text] [Related]
16. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Dusenbery KE; Potish RA; Argenta PA; Judson PL
Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
Sorbe B; Johansson B
Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in the treatment of uterine sarcomas. A retrospective analysis of 54 cases.
Hoffmann W; Schmandt S; Kortmann RD; Schiebe M; Dietl J; Bamberg M
Gynecol Obstet Invest; 1996; 42(1):49-57. PubMed ID: 8840179
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
[TBL] [Abstract][Full Text] [Related]
20. Results of postoperative radiotherapy in the treatment of 29 uterine sarcoma patients.
Etiz D; Garipağaoğlu M; Etiz EE; Köse FM; Kayikçioğlu F; Haberal A; Citak L; Cakmak A
Tumori; 2003; 89(2):183-8. PubMed ID: 12841668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
